Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Novel coronavirus schematic drawing surrounded by hemoglobin molecules

A new study led by RDM researchers analyses  iron levels in intensive care COVID-19 patients to find that patients with very low levels of iron had severe respiratory failure. The study, published in the journal Critical Care,  is part of an ongoing close collaboration between ICU academic clinicians Dr Akshay Shah and Dr Stuart McKechnie, and Professor Hal Drakesmith’s research group at the MRC WIMM.

Changes in iron levels have been associated with worsening disease for other viral infections such as HIV and Hepatitis C, but this is the first study to find a similar link for COVID-19.

Iron is essential for the growth of pathogens, but also for the body’s own immune response. So during an infection, the immune system ‘sequesters’ iron to deprive pathogens. At the same time, the immune system’s T and B lymphocytes (white blood cells that are a key art of the body’s immune response) need iron to clear the infection.

The researchers analysed blood samples collected from 30 critically ill COVID-19 patients when they were first admitted to the John Radcliffe Hospital in Oxford. The blood samples were collected within 24-48 hours of the patients being admitted, so they reflect the condition the patients were first admitted in, rather than their subsequent treatment.  

This analysis of the levels of iron in the blood serum found that patients with severe COVID-19 respiratory failure had very low levels of iron,compared to those with less severe disease. Low iron levels also correlated with fewer lymphocytes, which are the major players in the body’s ‘adaptive’ immune response: unlike innate immunity, which identifies and reacts to general threats, the adaptive immune response tailor-makes antibodies for pathogens it has previously encountered. Other studies have also reported low levels of T lymphocytes appear to correlate with more severe COVID-19 symptoms, so the correlation between low iron levels and lymphocyte numbers here suggests that iron may contribute to possible T-cell dysfunction too.

“It’s important to note that we don’t think that low levels of iron are causing worse COVID-19 disease,” says Dr Akshay Shah, the ICU doctor and researcher who is the lead author on this study. “Instead, iron may be a signal picking up on other processes linked to disease severity”

"Low concentrations of iron in the bloodstream are commonly observed in infections but we were surprised indeed by the very low level in severely ill COVID-19 patients,” said Professor Drakesmith.“We now need to investigate the causes and consequences of this phenomenon, and how it might contribute to the disease"

“The close collaborative links we have established between critical care and the Drakesmith Lab position us well to enable this” added Dr Stuart McKechnie, Consultant in Intensive Care Medicine at the John Radcliffe Hospital.

The group now plans to these investigations as part of the a larger programme within the International Severe Acute Respiratory and emerging Infection Consortium, which is evaluating samples from hospitalised patients. The investigations are part of a NIHR Oxford BRC funded study evaluating blood cell-related biomarkers associated with adverse outcomes in COVID-19 infections.

We want to hear about your news!

Publishing a paper? Just won an award? Get in touch with communications@rdm.ox.ac.uk

 

Similar stories

Biotech spinout MiroBio acquired by Gilead Sciences for ~£332m

Co-founded by Simon Davis, MiroBio focuses on developing therapeutics for inflammatory diseases.

Six RDM research groups secure LEAF Sustainability Awards

The Laboratory Efficiency Assessment Framework (LEAF) aims to support research groups to embed sustainability into their work.

Ewa Gogola receives Wellcome Early Career Award

Dr Ewa Gogola from the Patel Group in the MRC Molecular Haematology Unit has been awarded funding by the Wellcome Trust for the project ‘DNA damage-induced hepatocyte polyploidisation- how it happens and what are its consequences?’

Novel all-in-one vaccine developed to tackle future coronavirus threats

Up to $30 million in funding has been announced by the Coalition for Epidemic Preparedness Innovations (CEPI) to bring a new nanoparticle vaccine offering protection against a range of coronaviruses to clinical trial.

James Davies named as Lister Research Prize Fellow

James Davies has been named as one of eight researchers selected for the 2022 Fellowship scheme.

Understanding the interplay of dietary iron, anaemia and the immune system

Four related projects aim to unravel how the iron we eat shapes how the immune system develops and responds to vaccines.